Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
2.100
+0.120 (6.06%)
Jun 18, 2026, 4:00 PM EDT - Market closed
Serina Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.13 | 0.13 | 0.06 | 3.15 | 0.03 | 0.14 | |
Revenue Growth (YoY) | - | 132.14% | -98.22% | 9173.53% | -76.39% | -60.11% |
Cost of Revenue | - | - | - | - | 0.01 | 0.02 |
Gross Profit | 0.13 | 0.13 | 0.06 | 3.15 | 0.02 | 0.13 |
Selling, General & Admin | 11.17 | 11 | 9.62 | 3.89 | 5.97 | 6.71 |
Research & Development | 13.4 | 13.16 | 7.48 | 2.39 | 1.03 | 1.46 |
Other Operating Expenses | - | - | - | - | - | -0.11 |
Total Operating Expenses | 24.57 | 24.15 | 17.1 | 6.28 | 7 | 8.06 |
Operating Income | -18.16 | -24.02 | -17.05 | -3.13 | -6.98 | -7.93 |
Interest Expense | -0.4 | -0.21 | -0.53 | -0.56 | -3.34 | -1.1 |
Other Non-Operating Income (Expense) | 2.86 | 5.04 | 6.37 | 8.96 | -0.21 | 0.45 |
Total Non-Operating Income (Expense) | 2.45 | 4.83 | 5.84 | 8.4 | -3.55 | -0.65 |
Pretax Income | -15.71 | -19.2 | -11.21 | 5.27 | -10.52 | -8.58 |
Provision for Income Taxes | - | 0.02 | - | - | - | - |
Net Income | -21.29 | -19.22 | -11.21 | 5.27 | -10.52 | -8.69 |
Minority Interest in Earnings | -0.02 | -0.03 | -0.07 | - | -0.06 | -0 |
Earnings From Discontinued Operations | - | - | - | - | - | -0.11 |
Net Income to Common | -21.27 | -19.18 | -11.14 | 5.27 | -10.46 | -8.68 |
Shares Outstanding (Basic) | 11 | 10 | 7 | 2 | 2 | 1 |
Shares Outstanding (Diluted) | 11 | 10 | 7 | 7 | 2 | 1 |
Shares Change (YoY) | 8.24% | 38.47% | 0.11% | 242.70% | 99.12% | 0.58% |
EPS (Basic) | -2.00 | -1.91 | -1.51 | 2.36 | -1.25 | -8.09 |
EPS (Diluted) | -2.00 | -1.91 | -1.51 | 0.73 | -1.25 | -8.09 |
Free Cash Flow | -18.29 | -18.01 | -17.16 | -2.98 | -5.94 | -15.62 |
Free Cash Flow Per Share | -1.70 | -1.77 | -2.33 | -0.41 | -2.77 | -14.50 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 61.76% | 86.81% |
Operating Margin | -13972.30% | -18478.50% | -30442.90% | -99.24% | -20514.70% | -5509.03% |
Profit Margin | -16377.70% | -14780.80% | -20012.50% | 167.11% | -30947.10% | -6031.25% |
FCF Margin | -14065.40% | -13856.90% | -30641.10% | -94.51% | -17467.60% | -10847.20% |
EBITDA | -17.89 | -23.75 | -16.63 | -2.87 | -6.84 | -7.8 |
EBITDA Margin | -13763.10% | -18266.20% | -29691.10% | -90.87% | -20126.50% | -5418.06% |
EBIT | -18.16 | -24.02 | -17.05 | -3.13 | -6.98 | -7.93 |
EBIT Margin | -13972.30% | -18478.50% | -30442.90% | -99.24% | -20514.70% | -5509.03% |
Effective Tax Rate | - | -0.09% | 0.00% | 0.00% | 0.00% | 0.00% |